Subscribe to our Newsletters !!
Few developments in science and technology have be
In modern pharmaceutical and laboratory settings,
A new COVID-19 variant, BA.3.2, informally called
Alembic Pharmaceuticals Limited (Alembic) today an
2026 marks a new chapter for the pharmaceutical an
Tofu used to be associated with Asian cuisine, but
Dear Readers, Welcome to a fresh and forward-lo
Medication firm Zydus Cadila on Saturday said it has received final approval from the US health regulator to market generic Butalbital, Acetaminophen and Caffeine combination pills to cure symptoms of tension headaches.
The company has obtained final approval from that the United States Food and Drug Administration (USFDA) to market Butalbital, Acetaminophen and Caffeine tablets in strengths of 50mg/325mg/40 mg, Zydus Cadila said in a statement.
The drug will be manufactured in Nesher Pharma’s manufacturing facility at St. Louis in the united states, it added.
The group now has 294 approvals and has filed over 390 abbreviated new drug applications (ANDAs) because the commencement of the filing procedure, it included.
